Treatment of acne vulgaris without antibiotics: Tertiary amine-benzoyl peroxide combination vs. benzoyl peroxide alone (Proactiv Solution™)

International Journal of Dermatology

Volumn 46, Issue 1, 2007, Pages 89-93

  Burkhart, Craig G ^a,b,c   Burkhart, Craig N ^a,b,c  

^a MEDICAL COLLEGE OF OHIO   (United States)

^b University School of Osteopathic Medicine   (United States)

^c Department of North Carolina at Chapel Hill ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALLYLAMINE; ANTIBIOTIC AGENT; BENZOYL PEROXIDE; BUTENIFINE; PROACTIV SOLUTION; TERTIARY AMINE; UNCLASSIFIED DRUG;

ACNE VULGARIS; ADOLESCENT; ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL PROTOCOL; CLINICAL TRIAL; COMBINATION CHEMOTHERAPY; COMEDO; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE SEVERITY; DRUG EFFICACY; HUMAN; MONOTHERAPY; OPEN STUDY; PATIENT SATISFACTION; PILOT STUDY; RANDOMIZED CONTROLLED TRIAL; SKIN INFLAMMATION;

ACNE VULGARIS; ADMINISTRATION, TOPICAL; ADOLESCENT; ADULT; ALLYLAMINE; BENZOYL PEROXIDE; DERMATOLOGIC AGENTS; DRUG SYNERGISM; DRUG THERAPY, COMBINATION; HUMANS; PATIENT SATISFACTION; PILOT PROJECTS;

EID: 33845936466     PISSN: 00119059     EISSN: 13654632     Source Type: Journal    
DOI: 10.1111/j.1365-4632.2007.03081.x     Document Type: Article

References (31)

1. Burkhart CN, Burkhart CG. Microbiologic principle of biofilms as a major factor in pathogenesis of acne. Int J Dermatol 2003; 42: 925-927.
2. Velicer CM, Heckbert SR, Lampe JW. Antibiotic use in relation to the risk of breast cancer. J Am Med Assoc 2004; 291: 827-835.
3. Wolf R, Matz H, Parish LC. After the antibiotics and breast cancer study: What to tell patients. Skinmed 2004; 3: 125-127.
4. Simonart T. Antibiotic-resistant acne: Lessons from good sense. Br J Dermatol 2004; 150: 369-370.
5. Ross JI, Snelling AM, Carnegie E, et al. Antibiotic-resistant acne: lessons from Europe. Br J Dermatol 2003; 148: 467-478.
6. Eady EA, Cove JH, Holland KT, et al. Erythromycin-resistant propionibacteria in antibiotic-treated acne patients: Association with therapeutic failure. Br J Dermatol 1989; 121: 51-57.
7. Eady EA, Cove JH, Blake J, et al. Recalcitrant acne vulgaris. Clinical, biochemical and microbiological investigation of patients not responding to antibiotic treatment. Br J Dermatol 1988; 188: 415-423.
8. Leyden JJ, McGinley KJ, Cavalieri S, et al. Propionibacterium acnes resistance to antibiotics in acne patients. J Am Acad Dermatol 1983; 8: 41-45.
9. Cunliffe W. Propionibacterium acnes resistance and its clinical relevance. J Dermatol Treat 1995; 6: S3-S4.
10. Eady EA, Jones CE, Tipper JL, et al. Antibiotic resistant propionibacteria in acne: Need for policies to modify antibiotic usage. Br Med J 1993; 306: 555-556.
11. Kurokawa I, Nishijima S, Asada Y. The antibiotic susceptibility of Propionibacterium acne: A 15-year bacteriological study and retrospective evaluation. J Dermatol 1988; 15: 149-154.
12. Ross JI, Snelling AM, Eady EA, et al. Phenotypic and genotypic characterization of antibiotic-resistant Propionibacterium acnes isolated from acne patients attending dermatology clinics in Europe, the U.S.A., Japan and Australia. Br J Dermatol 2001; 144: 339-346.
13. Coates P, Vyakrnam S, Eady EA, et al. Prevalence of antibiotic-resistant propionibacteria on the skin of acne patients: 10-year surveillance data and snapshot distribution study. Br J Dermatol 2002; 146: 840-848.
14. Eady EA. Bacterial resistance in acne. Dermatology 1998; 196: 59-66.
15. Gollnick HPM, Krautheim A. Topical treatment in acne: Current status and future aspects. Dermatology 2003; 206: 29-36.
16. Eady EA, Gloor M, Leyden JJ. Propionibacterium acnes resistance: A worldwide problem. Dermatology 2003; 206: 54-56.
17. Tan HH. Topical antibacterial treatments for acne vulgaris: Comparative review and guide to selection. Am J Clin Dermatol 2004; 5: 79-84.
18. Burkhart CN, Specht K, Neckers D. Synergistic activity of benzoyl peroxide and erythromycin. Skin Pharmacol Appl Skin Physiol 2000; 13: 292-296.
19. Burkhart CG, Burkhart CN, Isham N. Expanded yeast and bacterial coverage: Synergistic activity by free radicals formed by combining an allylamine with benzoyl peroxide. Br J Dermatol 2006; 154: 341-344.
20. Warner GT, Plosker GL. Clindamycin/benzoyl peroxide gel: A review of its use in the management of acne. Am J Clin Dermatol 2002; 3: 349-360.
21. Eady EA, Farmery MR, Ross JI, et al. Effects of benzoyl peroxide and erythromycin alone and in combination against antibiotic-sensitive and - resistant skin bacteria from acne patients. Br J Dermatol 1994; 131: 331-336.
22. Gloor M, Pfahler E, Neumann W, et al. Topical treatment of acne vulgaris with erythromycin and benzoyl peroxide. Z Hautkr 1982; 57: 867-878.
23. Eady EA, Bojar RA, Jones CE, et al. The effects of acne treatment with a combination of benzoyl peroxide and erythromycin on skin carriage of erythromycin-resistant propionibacteria. Br J Dermatol 1996; 134: 107-113.
24. Gupta AK, Lynde CW, Kunynetz RA, et al. A randomized, double-blind, multi-center, parallel group study to compare relative efficacies of the topical gels 3% erythromycin/5% benzoyl peroxide and 0.025% tretinoin/ erythromycin 4% in the treatment of moderate acne vulgaris of the face. J Cutan Med Surg 2003; 7: 31-37.
25. O'Brien SC, Lewis JB, Cunliffe WJ. The Leeds revised acne grading system. J Dermatol Treat 1998; 9: 215-220.
26. Nemchik A, Badescu B, Phanstiel O. N-(benzoyloxy) amines: An investigation of their thermal stability, synthesis, and incorporation into novel peptide constructs. Tetrahedron 2003; 59: 4315-4325.
27. Vazquez B, Elvira C, Roman JS, et al. Reactivity of a polymerizable amine activator in the free radical copolymerization with methyl methacrylate and surface properties of copolymers. Polymer 1997; 38: 4365-4372.
28. Vazquez B, Elvira C, Levenfeld B, et al. Application of tertiary amines with reduced toxicity to the curing process of acrylic bone cements. J Biomed Mater Res 1997; 34: 129-136.
29. Moane S, Raftery DP, Smyth MR, et al. Decomposition of peroxides by transition metal ions in anaerobic adhesive cure chemistry. Int J Adhesion Adhesives 1999; 19: 49-57.
30. Vazquez B, Levenfeld B, Roman JS. Role of amine activators on the curing parameters, properties and toxicity of acrylic bone cements. Polymer Int 1998; 46: 241-250.
31. Leyden JJ. Current issues in antimicrobial therapy for the treatment of acne. Eur Acad Dermatol Venereol 2001; 15: S51-S55.